세계의 음성 바이오마커 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 기술별, 적응증별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Global Vocal Biomarker Market was valued at USD 2.01 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 9.32% through 2030. The Global Vocal Biomarker Market is a rapidly emerging and dynamic sector within the healthcare and technology industries, driven by the innovative integration of voice analysis and artificial intelligence. Vocal biomarkers are a revolutionary concept that leverages the wealth of information embedded in our voices to diagnose, monitor, and predict various medical conditions. This market is gaining substantial traction due to its non-invasive nature and the potential to transform healthcare by providing early detection and personalized treatment solutions. For instance, according to an article published in the National Library of Medicine titled "Voice as a Biomarker in Health-Tech: Mapping the Evolving Landscape of Voice Biomarkers in the Start-Up World," the use of voice as a biomarker is gaining traction in health technology. The study highlights the growing role of startups in leveraging voice-based analytics for health monitoring, diagnosis, and disease management, emphasizing the transformative potential of vocal biomarkers in the digital health landscape.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a significant driving force behind the burgeoning Global Vocal Biomarker Market. Chronic diseases, such as diabetes, cardiovascular conditions, respiratory disorders, and mental health issues, have reached epidemic proportions worldwide. These conditions often require continuous monitoring, early detection, and personalized interventions to manage effectively. Vocal biomarkers, which harness the power of voice analysis and artificial intelligence, have emerged as a non-invasive and cost-effective solution to address the challenges posed by these chronic health issues. For instance, non-communicable diseases (NCDs), including cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases, are long-lasting and non-transmissible, posing a growing global health challenge. In 2019, NCDs caused 12 million deaths in the Western Pacific Region. Despite earlier progress in reducing premature deaths, new risk factors and changing environments have reversed gains in some countries over the past decade. Additionally, in 2021, neurological conditions accounted for 443 million disability-adjusted life years (DALYs) lost to illness, disability, and premature death, surpassing cardiovascular diseases as the leading contributor to the global disease burden.

Vocal biomarkers offer a unique advantage in the management of chronic diseases by enabling the detection of subtle changes in a person's voice over time. For instance, in diabetes management, vocal biomarkers can aid in the remote monitoring of glucose levels and associated fluctuations. This innovative approach provides an unobtrusive way for individuals to track their health status, reducing the need for frequent clinic visits and empowering patients to take charge of their well-being.

Key Market Challenges

Privacy and Data Security Concerns

The Global Vocal Biomarker Market holds great promise in the field of healthcare, offering innovative solutions for the diagnosis and monitoring of various medical conditions through the analysis of voice data. However, its growth is significantly hindered by pressing privacy and data security concerns that cast a shadow over the adoption of this technology.

One of the foremost challenges that vocal biomarkers face is the handling and safeguarding of sensitive voice data. Voice recordings carry highly personal and identifiable information, making them a potential goldmine for malicious actors if not adequately protected. Patients and healthcare providers alike are rightfully concerned about the potential misuse or unauthorized access to such data.

Implementing robust encryption measures is fundamental to ensuring the security of voice data. Utilizing end-to-end encryption and other state-of-the-art data protection techniques can safeguard voice recordings throughout their collection, transmission, and storage.

Patients should have control over their voice data, and informed consent should be obtained before recording and analyzing their voices. Users must be aware of how their data will be used and have the ability to revoke access at any time.

Key Market Trends

Telemedicine and Remote Patient Monitoring

Telemedicine and remote patient monitoring are emerging as powerful drivers behind the surge of the Global Vocal Biomarker Market. These healthcare trends, accelerated by the COVID-19 pandemic, are reshaping the way medical services are delivered and are creating a favorable environment for the adoption of vocal biomarkers.

Telemedicine, which involves providing medical consultations and healthcare services remotely, has gained immense popularity due to its convenience and the imperative to maintain social distancing during the pandemic. Patients now have the option to record their voices using smartphones or specialized devices and share this data with healthcare providers for analysis. Vocal biomarkers, through their non-invasive nature, enable patients to actively participate in their own healthcare, allowing for the remote monitoring of various medical conditions, from mental health assessments to the diagnosis and monitoring of chronic diseases.

Key Market Players

• IBM Corporation
• Boston Technology Corporation
• EVOCAL Health
• Audio Profiling
• Cogito Corporation
• Kintsugi
• Sharecare Inc.
• Microtest Health
• Sonde Health
• AudEERING

Report Scope:

In this report, the Global Vocal Biomarker Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vocal Biomarker Market, By Technique:

• Frequency
• Amplitude
• Error Rate
• Vocal Rise or Fall Time
• Phonation Time
• Vocal Tremor
• Pitch
• Others

Vocal Biomarker Market, By Indication:

• Psychiatric Disorders
• Respiratory Disorders
• Cardiovascular Disorders
• Traumatic Brain Injury (TBI)
• Neurological disorders
• Other

Vocal Biomarker Market, By End User:

• Hospitals & clinics
• Ambulatory Surgical Services
• Others

Vocal Biomarker Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vocal Biomarker Market.

Available Customizations:

Global Vocal Biomarker Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Vocal Biomarker Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Technique (Frequency, Amplitude, Error Rate, Vocal Rise or Fall Time, Phonation Time, Vocal Tremor, Pitch, Others)
  • 4.2.2. By Indication (Psychiatric Disorders, Respiratory Disorders, Cardiovascular Disorders, Traumatic Brain Injury (TBI), Neurological disorders, Other)
  • 4.2.3. By End-User (Hospitals & Clinics, Ambulatory care Centers, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Technique
  • 4.3.2. By Indication
  • 4.3.3. By End-User
  • 4.3.4. By Region

5. Asia Pacific Vocal Biomarker Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique
  • 5.2.2. By Indication
  • 5.2.3. By End-User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Vocal Biomarker Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Technique
      • 5.3.1.2.2. By Indication
      • 5.3.1.2.3. By End-User
  • 5.3.2. India Vocal Biomarker Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Technique
      • 5.3.2.2.2. By Indication
      • 5.3.2.2.3. By End-User
  • 5.3.3. Australia Vocal Biomarker Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Technique
      • 5.3.3.2.2. By Indication
      • 5.3.3.2.3. By End-User
  • 5.3.4. Japan Vocal Biomarker Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Technique
      • 5.3.4.2.2. By Indication
      • 5.3.4.2.3. By End-User
  • 5.3.5. South Korea Vocal Biomarker Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Technique
      • 5.3.5.2.2. By Indication
      • 5.3.5.2.3. By End-User

6. Europe Vocal Biomarker Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique
  • 6.2.2. By Indication
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Vocal Biomarker Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By End-User
  • 6.3.2. Germany Vocal Biomarker Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By End-User
  • 6.3.3. Spain Vocal Biomarker Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By End-User
  • 6.3.4. Italy Vocal Biomarker Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Technique
      • 6.3.4.2.2. By Indication
      • 6.3.4.2.3. By End-User
  • 6.3.5. United Kingdom Vocal Biomarker Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Technique
      • 6.3.5.2.2. By Indication
      • 6.3.5.2.3. By End-User

7. North America Vocal Biomarker Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique
  • 7.2.2. By Indication
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Vocal Biomarker Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By End-User
  • 7.3.2. Mexico Vocal Biomarker Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By End-User
  • 7.3.3. Canada Vocal Biomarker Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By End-User

8. South America Vocal Biomarker Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique
  • 8.2.2. By Indication
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Vocal Biomarker Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By End-User
  • 8.3.2. Argentina Vocal Biomarker Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By End-User
  • 8.3.3. Colombia Vocal Biomarker Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By End-User

9. Middle East and Africa Vocal Biomarker Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique
  • 9.2.2. By Indication
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Vocal Biomarker Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By End-User
  • 9.3.2. Saudi Arabia Vocal Biomarker Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By End-User
  • 9.3.3. UAE Vocal Biomarker Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By End-User
  • 9.3.4. Egypt Vocal Biomarker Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Technique
      • 9.3.4.2.2. By Indication
      • 9.3.4.2.3. By End-User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Vocal Biomarker Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. IBM Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Boston Technology Corporation
• 14.3. EVOCAL Health
• 14.4. Audio Profiling
• 14.5. Cogito Corporation
• 14.6. Kintsugi
• 14.7. Sharecare Inc.
• 14.8. Microtest Health
• 14.9. Sonde Health
• 14.10.AudEERING

15. Strategic Recommendations

16. About Us & Disclaimer